Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience (Q36323993)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

adaptive radiation therapy

25 January 2020

main subject

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

D Van Den Weyngaert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

D Schrijvers

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

J Weyler

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

J B Vermorken

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Radiology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

1000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

367-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma

25 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Intensity-modulated radiotherapy for head-and-neck cancer in the community setting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Intensity-modulated radiation therapy for head and neck carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Intensity-modulated radiation therapy, protons, and the risk of second cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Intensity modulated radiation therapy in head and neck squamous cell carcinoma: state of the art and future challenges

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Applying radiobiological principles to combined modality treatment of head and neck cancer—The time factor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

30 September 2017

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Tolerances for the accuracy of photon beam dose calculations of treatment planning systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Application of a test package in an intercomparison of the photon dose calculation performance of treatment planning systems used in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Incidence of isolated regional recurrence after definitive (chemo-) radiotherapy for head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473465

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

22 September 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F67058055

Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer

21 January 2018

1 reference

12 December 2020

Beam Path Toxicities to Non-Target Structures During Intensity-Modulated Radiation Therapy for Head and Neck Cancer

1 reference

12 December 2020

Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region

1 reference

12 December 2020

Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx

1 reference

12 December 2020

Loss of local control with prolongation in radiotherapy

1 reference

12 December 2020

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Identifiers

DOI

10.1259/BJR/67058055

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

PubMed publication ID

21415302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21415302%20AND%20SRC:MED&resulttype=core&format=json